234 related articles for article (PubMed ID: 23110152)
1. Crystal structures of bovine CD1d reveal altered αGalCer presentation and a restricted A' pocket unable to bind long-chain glycolipids.
Wang J; Guillaume J; Pauwels N; Van Calenbergh S; Van Rhijn I; Zajonc DM
PLoS One; 2012; 7(10):e47989. PubMed ID: 23110152
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity.
Zajonc DM; Maricic I; Wu D; Halder R; Roy K; Wong CH; Kumar V; Wilson IA
J Exp Med; 2005 Dec; 202(11):1517-26. PubMed ID: 16314439
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
[TBL] [Abstract][Full Text] [Related]
4. The bovine CD1D gene has an unusual gene structure and is expressed but cannot present α-galactosylceramide with a C26 fatty acid.
Nguyen TK; Koets AP; Vordermeier M; Jervis PJ; Cox LR; Graham SP; Santema WJ; Moody DB; van Calenbergh S; Zajonc DM; Besra GS; Van Rhijn I
Int Immunol; 2013 Feb; 25(2):91-8. PubMed ID: 22968995
[TBL] [Abstract][Full Text] [Related]
5. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
[TBL] [Abstract][Full Text] [Related]
7. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
9. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
10. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
11. In contrast to other species, α-Galactosylceramide (α-GalCer) is not an immunostimulatory NKT cell agonist in horses.
Dossa RG; Alperin DC; Garzon D; Mealey RH; Brown WC; Jervis PJ; Besra GS; Cox LR; Hines SA
Dev Comp Immunol; 2015 Mar; 49(1):49-58. PubMed ID: 25445911
[TBL] [Abstract][Full Text] [Related]
12. Scavenger receptors target glycolipids for natural killer T cell activation.
Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
[TBL] [Abstract][Full Text] [Related]
13. Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.
Wang J; Li Y; Kinjo Y; Mac TT; Gibson D; Painter GF; Kronenberg M; Zajonc DM
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1535-40. PubMed ID: 20080535
[TBL] [Abstract][Full Text] [Related]
14. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
[TBL] [Abstract][Full Text] [Related]
15. Autoreactivity to Sulfatide by Human Invariant NKT Cells.
Stax AM; Tuengel J; Girardi E; Kitano N; Allan LL; Liu V; Zheng D; Panenka WJ; Guillaume J; Wong CH; van Calenbergh S; Zajonc DM; van den Elzen P
J Immunol; 2017 Jul; 199(1):97-106. PubMed ID: 28526683
[TBL] [Abstract][Full Text] [Related]
16. A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
Birkholz AM; Girardi E; Wingender G; Khurana A; Wang J; Zhao M; Zahner S; Illarionov PA; Wen X; Li M; Yuan W; Porcelli SA; Besra GS; Zajonc DM; Kronenberg M
J Immunol; 2015 Aug; 195(3):924-33. PubMed ID: 26078271
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice.
Freigang S; Zadorozhny V; McKinney MK; Krebs P; Herro R; Pawlak J; Kain L; Schrantz N; Masuda K; Liu Y; Savage PB; Bendelac A; Cravatt BF; Teyton L
J Clin Invest; 2010 Jun; 120(6):1873-84. PubMed ID: 20484813
[TBL] [Abstract][Full Text] [Related]
18. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
19. Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation.
Birkholz A; Nemčovič M; Yu ED; Girardi E; Wang J; Khurana A; Pauwels N; Farber E; Chitale S; Franck RW; Tsuji M; Howell A; Van Calenbergh S; Kronenberg M; Zajonc DM
J Biol Chem; 2015 Jul; 290(28):17206-17. PubMed ID: 26018083
[TBL] [Abstract][Full Text] [Related]
20. Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.
Tyznik AJ; Farber E; Girardi E; Birkholz A; Li Y; Chitale S; So R; Arora P; Khurana A; Wang J; Porcelli SA; Zajonc DM; Kronenberg M; Howell AR
Chem Biol; 2011 Dec; 18(12):1620-30. PubMed ID: 22195564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
